HBTA:NYE-Horizon Funds (USD)

ETF | Others |

Last Closing

USD 20.6027

Change

0.00 (0.00)%

Market Cap

N/A

Volume

4.13K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-13 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

-0.15 (-0.85%)

USD 65.72B
SGOV iShares® 0-3 Month Treasury B..

+0.01 (+0.01%)

USD 40.47B
JEPI JPMorgan Equity Premium Income..

+0.69 (+1.28%)

USD 36.19B
JPST JPMorgan Ultra-Short Income ET..

+0.06 (+0.12%)

USD 31.44B
DFAC Dimensional U.S. Core Equity 2..

+0.31 (+1.00%)

USD 29.60B
DTB DTE Energy Company 2020 Series

+0.08 (+0.47%)

USD 26.58B
JAAA Janus Detroit Street Trust - J..

+0.19 (+0.38%)

USD 21.14B
GBTC Grayscale Bitcoin Trust (BTC)

+0.85 (+1.28%)

USD 16.17B
CGDV Capital Group Dividend Value E..

+0.25 (+0.74%)

USD 14.38B
AVUV Avantis® U.S. Small Cap Value..

+0.64 (+0.81%)

USD 13.13B

ETFs Containing HBTA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike